Dr. Giridhar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2015 - 2018
University of California (San Francisco)Residency, Internal Medicine, 2013 - 2015- University of California (San Francisco)Internship, Internal Medicine, 2012 - 2013
University of Pittsburgh School of MedicineClass of 2012
Certifications & Licensure
CA State Medical License 2014 - Present
MN State Medical License 2015 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 18 citationsEvaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial.Tufia C Haddad, Vera J Suman, Antonino B D'Assoro, Jodi M Carter, Karthik V Giridhar
JAMA Oncology. 2023-06-01 - 69 citationsMale breast cancer in the United States: Treatment patterns and prognostic factors in the 21st centurySiddhartha Yadav, Dhauna Karam, Irbaz Bin Riaz, Hao Xie, Urshila Durani
Cancer. 2020-01-01 - 1 citationsSafety, efficacy, and tolerability of systemic therapies in male breast cancer: are there sex-specific differences?Siddhartha Yadav, Karthik V. Giridhar, Jodi L Taraba, Roberto A. Leon-Ferre, Kathryn J. Ruddy
Expert Opinion on Drug Safety. 2020-07-27
Press Mentions
Debunking Myths About CancerJune 10th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
